Briefs

ST. JOSEPH, Mich., April 19 /PRNewswire/ -- GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that N.V. Organon has licensed MetaCore(TM), GeneGo's platform for mining of high-throughput experimental data in the context of biological networks and human diseases. MetaCore(TM) is an enterprise platform being installed in the majority of the top pharmaceutical companies internationally. The suite includes a comprehensive, manually curated database which covers all levels of human cellular functionality, as well as rat, mouse, fly, worm and yeast orthologs, and functional information on over 3,000 human diseases and thousands of drugs connected with pathway targets. Organon plans to use MetaCore(TM) in pre-clinical research across various therapeutic areas and departments.

For more information, visit www.genego.com.